Overview

Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study will determine the efficacy and safety of citalopram compared to placebo in the treatment of children with autism.
Phase:
Phase 2
Details
Lead Sponsor:
Boston University
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Citalopram
Dexetimide